Emerging digital health technologies—including wearables, connected glucometers, blood pressure monitors, smart inhalers, and AI-based analytics—offer new opportunities for pharmacists to participate in continuous patient monitoring. These tools can generate real-time insights, enabling pharmacists to detect trends, identify adherence gaps, provide timely interventions, and personalize care plans. When effectively integrated into routine pharmacy workflows, digital monitoring has the potential to transform chronic disease management, improve patient engagement, and reduce preventable complications.

However, the successful adoption of these technologies requires careful attention to responsible implementation. Pharmacists must navigate challenges around data privacy, informed consent, interoperability, and equitable access. Embedding these tools into practice also demands thoughtful workflow design, staff training, and collaboration with healthcare providers, regulators, payers, and technology developers. Education is critical for pharmacists to fully realize this potential.

Chair:
-Dr Luna ElBizri, Founder and manager of Lunapharm Pharmacy, Lebanon.

Co-moderator:
-Dr Victoria Cardenas, Vice-dean for internationalisation, Institutional relations and postgraduate studies, University of Granada, Spain.

Panellists:
-Dr Paul Voigt, Inventory operations manager, Mediclinic, South Africa.
-Prof. Alpana Mair, Honorary Professor, Usher Institute, University of Edinburgh, UK.

*Please note that a Zoom account is required to register for this FIP Digital Event. If you are receiving an error message during registration, please create a Zoom account and use the corresponding email address for your registration.

Humanitarian crises take many forms, from armed conflict, displacement, natural disasters, to public health emergencies, and they continue to affect millions of people across the world. These crises place significant strain on healthcare systems, disrupting access to essential medicines and pharmaceutical care when people need them most. Pharmacists are often on the front line of humanitarian response, helping to maintain continuity of care and support affected communities. The involvement of pharmacists and pharmacy organisations in national emergency preparedness and response planning is therefore essential.

Moderator:

-Lars-Åke Söderlund, President-elect, FIP, Sweden.

Panellists: 

-Mr. Joan Peris Lluch, General director, Farmamundi, Spain .

-Rita de la Plaza, Treasurer, General Pharmaceutical Council of Spain, Spain.

-Sham Moodley, Consultant and Member of the Board of Directors, Independent Community Pharmacy Association (ICPA), South Africa.

-Dr. Helentina Pang ,Senior Pharmacist, Direct Relief, United States.

-Dr. Jeffrey Samuel, Regional Director, Africa, Direct Relief, United States.

*Please note that a Zoom account is required to register for this FIP Digital Event. If you are receiving an error message during registration, please create a Zoom account and use the corresponding email address for your registration.

Adeno-associated virus (AAV), a non-pathogenic single-stranded DNA virus that transduces both dividing and non-dividing cells, has emerged as a leading gene therapy platform. It persists primarily as an episode with a low insertional mutagenesis risk and elicits a comparatively mild
immune response. Eleven AAV-based therapies have been approved by the FDA Yet significant challenges limit how far the platform can go. Pre-existing neutralizing antibodies and treatment-induced immunogenicity restricts eligibility and blocks re-dosing, native packaging capacity is limited to ~4.7 kb, production still suffers from low yield and high empty-to-full capsid ratios, and finished products require stable formulations that needs to withstand ultra-low-temperature (≤ -60°C) storage, and controlled freeze-thaw without loss of potency. This presentation will discuss AAV's basic biology and structure, capsid engineering, manufacturing, purification, and
formulation advances and approaches to overcome these limitations.

Chair:
-Dr. Mathew Cherian PhD, FIP, USA.

Co-moderator:
Dr. Richard Ohene-Darkoh, Pharmaceutical Country Manager, Liberia.

Panellists:
-Dr. Subhro Guhathakurta PhD, Review Editor Frontiers in Molecular Neuroscience, USA.
-Dr. Sandeep Nema PhD, Ironwood Pharmaceuticals, USA.

*Please note that a Zoom account is required to register for this FIP Digital Event. If you are receiving an error message during registration, please create a Zoom account and use the corresponding email address for your registration.

This digital event in the advocacy micro-curriculum webinar series helps pharmacy students, educators, and practitioners turn evidence and community needs into persuasive policy briefs. Participants will distinguish policy briefs from position statements and advocacy toolkits and explore essential components: the problem, evidence, policy options, recommendations, and call to action. A practical walkthrough demonstrates how to assess local context, gather credible evidence, tailor recommendations, and prepare a brief for dissemination. The session also highlights student contributions, common pitfalls, useful resources, and strategies for translating completed briefs into advocacy action.

 Moderator:
-Dr. Mohamed Baraka, PhD, Vice President and Professor of Clinical Pharmacy Founder and CEO, Batterjee Medical College, Dubai, United Arab Emirates Intelligent Horizons, UAE.

Panelist /Speaker /Series Coordinator:
-Dr. Jeanine P. Abrons, PharmD, MS, FAPhA, Co-Director - University of Iowa Mobile Clinics Adjunct Associate Professor, Carver College of Medicine and College of Pharmacy, Lecturer - University of Technology, Jamaica Owner/founder, Travel Medica, USA.

Co-moderator:
-Rafie Hani Krachni, Student Pharmacist, Algeria.

Panellists:
-Dr. Abby A. Kahaleh, Global Accreditation Strategist, FIP, USA.
-Dr. Wafa Almadhagi, PhD, Associate Professor, Sana’a University, Yemen.
-Mancharee Sangmueang-Skallevold, PharmD, HR Management System Adoption Intern, Norwegian Refugee Council/Norway; Master's Student; Pharmacist, Norway & Thailand.
-Prof. Hoai-An Truong, PharmD, MPH, FNAP, FAPhA, Professor and Director of Public Health, FIP, USA.

Psoriasis is a chronic condition that can significantly affect people’s health, wellbeing and quality of life. Pharmacists are well placed to support people living with psoriasis, but this requires an understanding of the condition, its impact on daily life and the challenges people face with treatment. Bringing together dermatology, patient and pharmacy perspectives, this event will explore the importance of early recognition and referral, the challenges and support needs of people living with this condition, and practical approaches pharmacists can use to support appropriate medicine use, address treatment concerns, promote self-management and improve day-to-day care.

Moderator:
-Mrs Teresa Almeida, Community Pharmacist and Board Member of ANF, ANF - National Association of Pharmacies, Portugal.

Panellists:
-Dr Deepak Balak, Dermatologist, Leiden University Medical Center, The Netherlands.
-Ph.D Elisa Martini, Policy and Advocacy Manager, International Federation of Psoriasis Associations (IFPA), Sweden.
-Ms Chizaram Amarauche Chukwu, Consultant Pharmacist, Federal Medical Centre Abuja/Speckles Beauty, Nigeria.

*Please note that a Zoom account is required to register for this FIP Digital Event. If you are receiving an error message during registration, please create a Zoom account and use the corresponding email address for your registration.